Off-label Medicine Combinations Are Predominant Treatment In Survey Of Schizophrenics

Researchers report that 74.5 percent of 200 community-based schizophrenic patients, who were interviewed and evaluated (including a review of clinical records), were treated with off-label medication treatments. Specifically, 42.5 percent of subjects reported they were simultaneously treated with more than one antipsychotic drug, an unapproved treatment for schizophrenia. The most common unapproved drug combination was the use of both an antipsychotic drug and a mood stabilizer (45 percent of patients).

Read the whole article on Science Daily

More from Science Daily